| Financial Year |
March 31 2023 |
| Monetary Funds |
1,758,633,026.64 |
| Held-for-trading Financial Assets |
246,076,000.70 |
| Notes Receivable |
433,469,017.64 |
| Accounts Receivable |
3,744,134,518.68 |
| Advances to Suppliers |
375,032,031.72 |
| Other Receivables |
221,305,433.26 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,408,243,615.01 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
153,837,083.32 |
| Other Current Assets |
210,061,836.40 |
| Total Current Assets |
11,652,665,511.36 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
109,343,653.05 |
| Investment Properties |
10,209,159.33 |
| Fixed Assetes |
3,154,482,535.98 |
| Under-construction Projects |
1,042,370,001.19 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
659,260,294.98 |
| R&D expenses |
11,796,318.78 |
| Goodwill |
27,051,704.64 |
| Long-Term Deferred and Prepaid Expenses |
6,880,889.68 |
| Deferred Income Tax Assets |
137,348,555.16 |
| Other Non-Current Assets |
243,537,013.11 |
| Sub-Total of Non-Current Assets |
5,454,466,661.28 |
| Total Assets |
17,107,132,172.64 |
| Short-Term Loans |
5,347,309,262.31 |
| Trading Financial liabilities |
-- |
| Notes Payable |
327,218,852.79 |
| Accounts Payable |
1,035,847,714.96 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
104,919,018.71 |
| Taxes Payable |
79,790,851.04 |
| Interest Payable |
-- |
| Dividend Payable |
4,373,924.43 |
| Other payables |
166,986,073.15 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
701,491,490.41 |
| Other Current Liabilities |
90,319,685.71 |
| Sub-Total of Current Liabilities |
7,930,170,378.05 |
| Long-term Loans |
2,759,234,683.97 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
23,584,530.85 |
| Other Non-Current Liabilities |
6,631,666.68 |
| Sub-Total of Non-Current Liabilities |
3,054,740,062.65 |
| Total Liabilities |
10,984,910,440.70 |
| Paid-In Capital(Or Share Stock) |
616,956,965.00 |
| Capital Surplus |
1,527,182,560.74 |
| Surplus Reserve |
141,588,851.54 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,498,653,820.78 |
| Minority Stockholder's Interest |
213,598,128.25 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,908,623,603.69 |
| Owner's Equity（Stockholder's Equity） |
6,122,221,731.94 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
17,107,132,172.64 |
